scholarly journals A retrospective review of cancer surveillance in 100 head and neck cancer patients: Is there scope for a more tailored approach?

2021 ◽  
Author(s):  
Muhammad Ibaad Ur Rehman Alvi ◽  
Eli Jack Eagles ◽  
David W. Hamilton
2016 ◽  
Vol 32 (3) ◽  
pp. 330-335 ◽  
Author(s):  
Joel Franco ◽  
Alhasan N. Elghouche ◽  
Michael S. Harris ◽  
Mimi S. Kokoska

A retrospective review of 100 sequential patients (2009-2012) with head and neck cancer was performed to determine the frequency of 5 types of diagnostic delays and errors outlined by the Institute of Medicine. There were a total of 105 diagnostic delays/errors. The most common was delay in being seen in the otolaryngology clinic after referral placement (28.6%), followed by diagnostic error by the referring physician (22%), delay in referral of a symptomatic patient to the otolaryngology clinic (16.2%), delay in employing an appropriate diagnostic test or procedure (15.2%), delay in action following reporting of pathology or imaging results for an incidental lesion (11.4%), diagnostic error by the otolaryngology clinic (2.8%), delay in action following reporting of pathology or imaging results for the symptomatic lesion (2.8%), and use of outmoded tests or therapy (1%). Increased awareness of these types of delays/errors will direct actions and processes to reduce or eliminate them.


Author(s):  
muhammad ibaad ur rehman alvi ◽  
Eli Jack Eagles ◽  
David Hamilton

5 succinct/key points 1. There is a considerable burden to outpatient head and neck cancer (HaNC) surveillance, and it is unclear to what extent the current recommendations facilitate the detection of HaNC. 2. Our 100 patient retrospective analysis demonstrated three asymptomatic recurrences (all within the first year of follow up) and 20 symptomatic recurrences (mean time to recurrence of 21.4 months). 3. Seventy-four percent of those patients who recurred did so within the first two years following primary treatment, increasing up to 83% by three years. 4. We believe the value of routine follow up is more apparent within the first two to three years following primary treatment as this is when the rate of recurrence is highest. 5. We anticipate larger trials investigating the efficacy of an initial two years of frequent follow up followed by longer-term patient-led follow up.


Skull Base ◽  
2007 ◽  
Vol 17 (S 2) ◽  
Author(s):  
Federico Ampil ◽  
Cherie Nathan ◽  
Gloria Caldito ◽  
Anil Nanda ◽  
Timothy Lian

Sign in / Sign up

Export Citation Format

Share Document